Drug Trial Radar · NCT00608023
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
Last checked: Nov 20, 2026Latest source record: Sep 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
263
Actual
Start
Aug 2007
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- TheratechnologiesIndustry
- Sponsor type
- Industry
- First posted
- Feb 6, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Assessing the Efficacy and Long-Term Safety of a 2 mg dose of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Subjects with Excess Abdominal Fat Accumulation
Conditions
- Lipodystrophy
- HIV Infections
Interventions
TesamorelinDrug
Placebo for TesamorelinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes From Baseline in Fasting Blood Glucose at Week 52Time frame: Baseline and Week 52
- Changes From Baseline in 2 h Oral Glucose Tolerance Test (OGTT) at Week 52Time frame: Baseline and Week 52
Locations
47 sites in 6 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Body Positive Inc.
Phoenix, Arizona
Somero, Michael
Indio, California
UCLA School of Medicine
Los Angeles, California
Office of Dr. Michael Somero
Palm Springs, California
University of California
San Francisco, California
Kaiser Permanente
San Francisco, California
UCSF/VA Medical Center
San Francisco, California
AIDS Research Alliance
West Hollywood, California
Denver Public Health Department
Denver, Colorado
Office of Dr. Gary Richmond
Fort Lauderdale, Florida
Hendry/Glades County Health Departments
LaBelle, Florida
Infectious Disease Research Institute Inc.
Tampa, Florida
AIDS Research Consortium Atlanta (ARCA)
Atlanta, Georgia
Northern Healthcare
Chicago, Illinois
Northstar Medical
Chicago, Illinois
Indiana University Department of Medicine
Indianapolis, Indiana
Tufts University School of Medicine
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
The Research Institute
Springfield, Massachusetts
ID Associates
Hillsborough, New Jersey
AIDS Community Research Initiative of America
New York, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
University Hospitals of Cleveland
Cleveland, Ohio
Central Texas Clinical Research
Austin, Texas
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
Swedish Medical Center
Seattle, Washington
C. H. U. Sart-Tilman
Liège, Belgium
St-Paul's Hospital
Vancouver, British Columbia, Canada
McMaster University Health Sciences Centre
Hamilton, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
Centre Hospitalier Universitaire de Santé de l'Estrie
Fleurimont, Quebec, Canada
Montreal General Hospital
Montreal, Quebec, Canada
Groupe de Recherche en Rhumatologie et maladies osseuses
Ste-Foy, Quebec, Canada
Hôpital Hotel Dieu Lyon
Lyon, France
Hotel Dieu
Nantes, France
Hopital Europeen Georges Pompidou
Paris, France
Hopital Necker
Paris, France
Hosp. Ramon y Cajal
Madrid, Spain
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.